PATENT CLAIM ANALYSIS

Application Number: 16129867
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "471000"]

Abstract:
The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.

Claim (Index 15):
The method of  claim 14 , wherein the method further comprises administering to the human at least one additional anti-cancer agent.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.37143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15314124', '15175363', '15502356', '15799771', '14354500']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7780793306219923
- 35 USC 102 Novelty (BERT): 0.5918868043132635
- Combined Prediction Score: 0.7594600779911194
- Mean Citation Score: 405.007728
- Max Citation Score: 570.4564
- Similarity Product: 386.2960841982604

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test